Global Industry Analysts, Inc., Jan 2011, Pages: 521
Factors
Erythropoietins
Colony Stimulating Factors
Interferons
Interleukins
Tissue Growth Factors
2. INTRODUCTION
Growth Factors: A Preface
Current and Future Analysis
Analysis By Region
Global Industry Analysts, Inc., Oct 2008, Pages: 576
(includes corresponding Graph/Chart) II-64
Table 11: World Recent Past, Current & Future Analysis for
Blood Growth Factors by Type - Erythropoietins, Colony
Stimulating Factors, Interferons
ICON Group International, Jan 2011, Pages: 329
fall along a "long-run" aggregate consumption function. This long-run function applies despite some of these countries having wealth, current income dominates the latent demand for erythropoietins. So
Global Industry Analysts, Inc., July 2009, Pages: 1810
corresponding Graph/Chart) II-1
The Regional Impact II-1
Emerging Markets to Drive Growth II-2
Biotechnology II-2
Biotech Bankruptcies Rife in the Current Economic Downturn II-3
Economic Downturn Takes Toll on R
ICON Group International, Jan 2011, Pages: 56
despite some of these countries having wealth, current income dominates the latent demand for erythropoietins in Africa. So, latent demand in the long-run has a zero intercept. However, I allow firms
ICON Group International, Jan 2011, Pages: 56
. This long-run function applies despite some of these countries having wealth, current income dominates the latent demand for erythropoietins in Asia & the Middle East. So, latent demand in the long-run has
ICON Group International, Jan 2011, Pages: 54
despite some of these countries having wealth, current income dominates the latent demand for erythropoietins in Europe. So, latent demand in the long-run has a zero intercept. However, I allow firms
ICON Group International, Jan 2011, Pages: 35
applies despite some of these countries having wealth, current income dominates the latent demand for erythropoietins in Latin America. So, latent demand in the long-run has a zero intercept. However, I
ICON Group International, Jan 2011, Pages: 37
. This long-run function applies despite some of these countries having wealth, current income dominates the latent demand for erythropoietins in North America & the Caribbean. So, latent demand in the long-run
ICON Group International, Jan 2011, Pages: 34
despite some of these countries having wealth, current income dominates the latent demand for erythropoietins in Oceana. So, latent demand in the long-run has a zero intercept. However, I allow firms
ICON Group International, Jan 2011, Pages: 195
despite some of these countries having wealth, current income dominates the latent demand for erythropoietins. So, latent demand in the long-run has a zero intercept. However, I allow firms to have
ICON Group International, Jan 2011, Pages: 142
of these cities fall along a "long-run" aggregate consumption function. This long-run function applies despite some of these states having wealth; current income dominates the latent demand for erythropoietins. So
ICON Group International, Jan 2011, Pages: 319
territories having wealth; current income dominates the latent demand for erythropoietins. So, latent demand in the long-run has a zero intercept. However, I allow different propensities to consume (including
ICON Group International, Jan 2011, Pages: 141
of these cities fall along a "long-run" aggregate consumption function. This long-run function applies despite some of these prefectures having wealth; current income dominates the latent demand for erythropoietins
GBI Research, Dec 2010, Pages: 198
that the competitive landscape of the global biotechnology industry is dynamic and will change in the near future. Currently, Roche/Genentech is the global leader in the biotechnology industry with revenues from
ICON Group International, Jan 2011, Pages: 731
of these cities fall along a "long-run" aggregate consumption function. This long-run function applies despite some of these states having wealth; current income dominates the latent demand for erythropoietins. So
RNCOS E-Services Private Limited, March 2011, Pages: 60
, and the government support.
The US generics market is anticipated to grow at a CAGR of around 10% during 2010-2013, says our recent research report “Booming US Generic Drug Market”. Currently
ICON Group International, July 2009, Pages: 329
fall along a "long-run" aggregate consumption function. This long-run function applies despite some of these countries having wealth, current income dominates the latent demand for erythropoietins. So
ICON Group International, May 2009, Pages: 54
despite some of these countries having wealth, current income dominates the latent demand for erythropoietins in Europe. So, latent demand in the long-run has a zero intercept. However, I allow firms
